Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sangyo Eiseigaku Zasshi ; 65(1): 1-8, 2023 Jan 25.
Artículo en Japonés | MEDLINE | ID: mdl-35569932

RESUMEN

Genetic and environmental factors and their interactions cause diseases and deteriorate health (Genetic and Environmental Interaction). Exposure to environmental factors plays a major role in the deterioration of health in the workplace.Occupational asthma (OA) is a common disorder in the workplace. Approaches to OA are well described and discussed in "Japanese Guideline for Diagnosis and Management of Occupational Allergic Diseases" by the Japanese Society of Occupational and Environmental Allergy. According to the guideline, OA and work-aggravated asthma comprise work-related asthma, and OA can be further divided into two disease entities: sensitizer-induced OA and irritant-induced OA. The guidelines also describe diagnostic and therapeutic strategies for OA. Since a definitive diagnosis of OA requires a comprehensive decision based on a detailed interview on clinical symptoms related to employment status and clinical tests, including inhalation tests of suspected substances as needed, the possibility of OA should be considered as the first step toward diagnosis of the patient. Otherwise, OA may not be diagnosed. Therapeutic strategies include exposure avoidance, environmental arrangements in the workplace, utilization of social resources for workers, and conventional pharmacotherapy for asthma.Artificially synthesized small compounds are used in various industries and can cause allergies. For example, isocyanates are small compounds in the -NCO group, which have been toxicologically studied. It was later shown that isocyanate could cause various nontoxic adverse health effects, including allergic reactions. Since small agents with low molecular weights bind to proteins, detecting their specific immunoglobulin E (IgE) antibodies targeting small compounds is generally difficult. In contrast, isocyanate-specific IgE antibodies are detectable in individuals with isocyanate allergies.Suspecting OA is essential in cases exposed to newly synthesized compounds, or to those that are already known but applied to new uses, which can be better understood and predicted by studying the health effects of isocyanates.Academic interest in various issues related to allergies, immunology, and toxicology in the workplace includes clinical medicine, epidemiology, and epigenetics related to environmental exposure. Further advanced research in these areas is necessary and promising.


Asunto(s)
Asma Ocupacional , Medicina Clínica , Enfermedades Profesionales , Exposición Profesional , Humanos , Exposición Profesional/efectos adversos , Exposición Profesional/prevención & control , Asma Ocupacional/inducido químicamente , Asma Ocupacional/diagnóstico , Asma Ocupacional/prevención & control , Enfermedades Profesionales/inducido químicamente , Enfermedades Profesionales/diagnóstico , Enfermedades Profesionales/prevención & control , Isocianatos/efectos adversos , Inmunoglobulina E/efectos adversos
2.
Mol Clin Oncol ; 1(1): 124-130, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24649134

RESUMEN

The efficacy of adjuvant chemotherapy with S-1 in patients with completely resected non-small cell lung cancer (NSCLC) has yet to be clarified, and the appropriate schedule for the adjuvant chemotherapy with S-1 remains unknown. A phase II study was conducted to evaluate the feasibility and efficacy of adjuvant chemotherapy with S-1. Patients enrolled in this study were 20-75 years old, had pathological stage IB-IIIA NSCLC, and had received complete resection of NSCLC. S-1 (80 mg/m2) was administered orally to the patients for four weeks followed by a two-week rest period (conventional schedule), for a maximum of eight cycles. The primary endpoint was relative dose intensity (RDI), while the secondary endpoints were safety and 1 year of disease-free survival (1y-DFS). Between May 2007 and October 2009, 28 patients were enrolled. The RDI was 63.1% (95% CI, 48.6-77.7). No grade 3 or worse hematological toxicity was observed. Grade 3 non-hematological toxicities were observed in four patients. No grade 4 or worse hematological toxicity was detected. The probability of 1y-DFS was 85.7% (95% CI, 72.8-98.6). In the subgroup analysis, the median RDI of patients over 65 years old was lower compared to the other patients (44.8 vs. 100%; P=0.013; Mann-Whitney U test). Creatinine clearance (CCr) was lower in the older group, with more grade 2 or 3 non-hematological toxicities in the elderly patients. These results suggest that the conventional schedule of adjuvant chemotherapy with S-1 is not likely to be feasible in older patients with completely resected NSCLC.

3.
Allergol Int ; 60(4): 459-65, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21681018

RESUMEN

BACKGROUND: The effect of inhaled corticosteroid (ICS) on the bone status of asthmatic patients is still uncertain, because it can differ by race and because there have been few cases in Japan. In this study, the bone status of ICS users with asthma was evaluated in an actual clinical setting in Japan. METHODS: In 7 participating hospitals, ICS users with asthma and control subjects were age- and gender-matched and recruited into this study. To assess bone status, ultrasound measurements of each individual's calcaneus were made using an AOS-100. The ratio of the osteo sono-assessment index (OSI) to the average OSI corrected for age and gender was denoted as %OSI and used for quantitative assessment. The second %OSI measurement was performed 6 months after the first %OSI one. During the study period, individual treatment remained unchanged. RESULTS: There were no significant differences in the 1st and 2nd %OSI between the ICS users and control subjects. However, the 2nd %OSI significantly decreased compared with 1st %OSI in female ICS users, although there were no significant changes in the male and female control subjects and male ICS users. CONCLUSIONS: The 6 month management of asthma in the actual clinical setting, including regular ICS use, might have a harmful influence on the bone status of female asthmatic patients. It may be necessary to manage and treat female patients for potent corticosteroid-induced osteoporosis, although further analyses of bone status in asthma patient ICS users will be required.


Asunto(s)
Corticoesteroides/efectos adversos , Antiasmáticos/efectos adversos , Asma/tratamiento farmacológico , Huesos/efectos de los fármacos , Huesos/diagnóstico por imagen , Administración por Inhalación , Corticoesteroides/administración & dosificación , Anciano , Antiasmáticos/administración & dosificación , Asma/complicaciones , Calcáneo/diagnóstico por imagen , Calcáneo/efectos de los fármacos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ultrasonografía
4.
Ann Thorac Cardiovasc Surg ; 16(4): 273-5, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21057446

RESUMEN

We report herein a technique for the repair of recurrent diaphragmatic hernia after repair of diaphragmatic rupture. Although chest roentgenography and computed tomography in a patient who presented with postprandial abdominal pain demonstrated a left intrathoracic intestinal shadow, the hernia was disregarded. To repair a diaphragmatic rupture along with intrathoracic adhesions, we performed adjunctive thoracotomy coupled with laparotomy. This report demonstrates the need for consideration of previous injuries, the value of combined thoracotomy and laparotomy, and the utility of repair using nonabsorbable sutures in the management of diaphragmatic hernia.


Asunto(s)
Hernia Diafragmática Traumática/cirugía , Humanos , Laparotomía , Masculino , Persona de Mediana Edad , Recurrencia , Reoperación , Suturas , Toracotomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...